Navigation Links
RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments
Date:1/13/2009

ss release as a result of new information, future events or otherwise.

About Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs, innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group's continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 97,000 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.

References

(1) Ohtsu, A et al. Multicenter phase II study of RAD001 for previously treated metastatic gastric cancer. Presented at the American Society of Clinical Oncology's 2009 Gastrointestinal Cancers Symposium, January 15, 2008.

(2) American Cancer Society. Detailed Guide: Stomach Cancer. Available at :

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
2. RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
3. Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments
4. RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer
5. RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors
6. Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer
7. RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
10. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
11. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015   Physicians Rx ... Bernstein has joined the organization as President and ... recently served as President and Chief Executive Officer for ... Chief Executive Officer of Physicians Rx Pharmacy, be responsible ... "We are extremely pleased to bring Gaston on ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hcb7bz/pharmaceutical ) has announced the addition of the ... 2015)" conference to their offering. Regulatory requirements for the ... Peru , Brazil , Mexico ... Paraguay , Venezuela , ... This seminar can be viewed both as an ...
(Date:9/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/cnq7tc/medical_device ... "Medical Device Studies: Clinical Evidence (London, UK - ... This course has been designed ... clinical evidence required for medical devices and in-vitro ... medical devices and the emphasis on high quality, ...
Breaking Medicine Technology:Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2Pharmaceutical Regulatory Affairs in Latin America Seminar - London, UK - November 16-18, 2015 2Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2
... Mich., Dec. 6, 2010 Stryker Corporation (NYSE: ... into a definitive agreement with Olympus Corporation for the ... Implant, OP-1 Putty, Opgenra and Osigraft, for use in ... includes the sale of the manufacturing facility in Lebanon, ...
... MONTGOMERY, Ala., Dec. 6, 2010 It was announced this ... by DePuy Orthopaedics , a subsidiary of Johnson & ... District of Ohio under U.S. District Judge David A. Katz. ... indicated patients who received the parts required a much higher ...
Cached Medicine Technology:Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus 2Federal Lawsuits Involving Defective Hip Replacement Parts Consolidated In Ohio 2
(Date:9/2/2015)... ... ... Amada Senior Care, premier provider of in-home care and assisted living placement ... location. Amada franchise partners Mike and Mell Fleming came to the senior care industry ... years in medical device sales while Mell spent over 30 years as a registered ...
(Date:9/2/2015)... ... September 02, 2015 , ... SonicSurg ... extremity surgical market, announced today that more than 600 successful patient procedures have ... hand. Plus, nearly 70 of these procedures have been on triggering thumbs. ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... records and case management solutions and services to both government and commercial clients, ... and Image Clean-up utility for IBM’s Datacap document capture platform. EDAC PurePAGE ...
(Date:9/2/2015)... ... September 02, 2015 , ... On September 9, 2015, ... doTERRA’s annual convention, the largest single-company convention to date for the state of Utah. ... forward to a tremendous event,” states David Stirling, doTERRA CEO. “One of the most ...
(Date:9/2/2015)... ... September 02, 2015 , ... “ G-Hold ” was featured ... coolest technology products available to consumers. Amanda Forstrom, a technology expert and special reporter ... for people to comfortably hold a tablet while reducing the likelihood of it dropping. ...
Breaking Medicine News(10 mins):Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2
... Democratic leadership and State delegations as a possible solution to national ... ... 29, 2008 -- If there has been any one consistent message ... been the party platform initiative to resolve our national health care ...
... online financial planning calculators available to people with disabilities. , ... ... to move forward after a diagnosis of a long-term disability is ... as they can to understand their financial options, according to ...
... and local government clients to engage via GSA. , ... ... emerging software engineering firm dedicated to the life sciences, announced ... GSA IT Schedule 70 provides government customers with the ability to ...
... found , , THURSDAY, Aug. 28 (HealthDay News) -- Working ... for people who have survived a stroke and gone ... , "You address two problems these patients have," said ... neurology and neurorehabilitation at the University of Zurich in ...
... VIEW, Calif., Aug. 28 The 2008 European,Hemodialysis Emerging ... in recognition of its pioneering Redsense -- a unique ... during hemodialysis,and may save the lives of many patients"., ... sensor patch. The sensor is,connected to the alarm using ...
... Aug. 28 ISTA Pharmaceuticals,Inc. (Nasdaq: ISTA ... Thomas Weisel,Partners Healthcare Conference at 11:30 a.m. Eastern ... Seasons Hotel in Boston, MA., ISTA,s President ... provide an update on the Company,s commercial and ...
Cached Medicine News:Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Social Security Disability Can Be Key to Financial Future 2Health News:Social Security Disability Can Be Key to Financial Future 3Health News:Social Security Disability Can Be Key to Financial Future 4Health News:Social Security Disability Can Be Key to Financial Future 5Health News:Social Security Disability Can Be Key to Financial Future 6Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2Health News:Treadmill Workouts Help Stroke Survivors 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 3
... Vascular Graft, the newest vascular graft offering ... leader in vascular surgical products for more ... reducing kinking and compression problems that ... graft provides all of the benefits of ...
... rasping necessary in cruciate ligament reconstruction procedures ... bone surface. This condition, if not rectified ... cruciate replacement. The GORE SMOOTHER Crucial Tool ... procedures. The tool functions as both a ...
Vikingselect™ Intra-Operative Monitoring (IOM)....
... system has been designed by practicing ... of the ever changing and demanding ... analyzing data from multiple modalities, including: ... and multiple patients at multiple sites. ...
Medicine Products: